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Abstract
Genetic mapping on fully sequenced individuals is transforming our understanding of the
relationship between molecular variation and variation in complex traits. Here we report a
combined sequence and genetic mapping analysis in outbred rats that maps 355 quantitative trait
loci for 122 phenotypes. We identify 35 causal genes involved in 31 phenotypes, implicating
novel genes in models of anxiety, heart disease and multiple sclerosis. The relation between
sequence and genetic variation is unexpectedly complex: at approximately 40% of quantitative
trait loci a single sequence variant cannot account for the phenotypic effect. Using comparable
sequence and mapping data from mice, we show the extent and spatial pattern of variation in
inbred rats differ significantly from those of inbred mice, and that the genetic variants in
orthologous genes rarely contribute to the same phenotype in both species.
Introduction
Unraveling the complex relationship between phenotype and genotype poses a formidable
challenge for biomedical science. Despite considerable success in identifying genetic loci
that contribute to quantitative variation and disease susceptibility in humans1, in most
organisms the causal genetic variants at loci that contribute to complex phenotypes remain
unclear2. Finding the responsible molecular changes would allow us to understand how
phenotypic variation arises and confirm the identity of relevant genes.
In this report we present results from an outbred rat heterogeneous stock (hereafter NIH-HS)
in a combined sequence-based and genetic mapping analysis of 160 phenotypes. The NIH-
HS, established in the 1980s in NIH, is descended from eight inbred progenitors, BN/SsN,
MR/N, BUF/N, M520/N, WN/N, ACI/N, WKY/N, and F344/N3, containing segregating
variation representative of commonly used laboratory rats.
Heterogeneous stocks (HS) have three characteristics suited to genetic mapping: (i)
quantitative trait loci (QTLs) can be resolved to megabase resolution; (ii) the complete
sequence of genotyped HS animals can be imputed with high accuracy from the progenitor
genomes; (iii) the population has a well-defined haplotype space that can be exploited to
determine whether genetic association is caused by single sequence variants or by
haplotypes4-6. This distinction is fundamental to understanding the signals from genome
wide association studies, where it is unknown how often causality can be attributed to a
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single variant. In natural populations it is rarely feasible to test for haplotypic effects
because of the difficulty of estimating the large number of unknown rare haplotypes7.
Here we describe the sequence of the eight progenitors, the development of a rat SNP array,
the genotyping and phenotyping of 1,407 outbred NIH-HS rats, and the mapping of
hundreds of quantitative trait loci (QTLs). We use the haplotypic properties of the NIH-HS
to investigate the molecular basis of these QTLs.
Results
Sequence analysis
We generated sequence data equivalent to an average of 22X SOLiD coverage of the eight
NIH-HS inbred founder strains. After mapping to the reference strain (BN/NHsdMcwi8) we
report our results with respect to an accessible genome, which represents ~88% of the
reference genome (Table 1). We identified 7.2M SNP sites (containing 19.8M genotypes
differing from the reference in at least one strain), 633,000 indels (<10bp with the majority
consisting of one (79.3%) or two (12.3%) basepair changes) and 44,000 structural variants.
We assessed the sensitivity and specificity of variant calls by comparison with 2.1 Mb of
DNA from one non-reference strain, LE/Stm, finished to an estimated accuracy of one error
per 100,000 bp9. Although LE/Stm is not an NIH-HS progenitor strain, it is one of the few
non-reference rat strains cloned into a library of bacterial artificial chromosomes (BACs) (so
suitable for highly accurate clone based sequencing)9 and one that is similarly diverged from
the reference strain (BN/NHsdMcwi). Comparison of SOLiD and capillary variant calls
showed 2.7% of SNPs, 2.2% of indels and 16.7% of structural variants were false positive
calls. These error rates were independently confirmed in the NIH-HS strains by analysis of a
randomly selected subset of variants using PCR-based resequencing, which confirmed all
selected SNPs (84/84) and indels (80/80) and most of the called structural variants (53/54).
In contrast, false-negative rates were much higher: 17.2% for SNPs, 41.4% for indels and
65% for structural variants. Most false-negative SNPs and indels are next to repeats (77.9
and 80.8% respectively).
Table 1 summarises the variation in each strain. Excluding BN/SsN (which is a sub-strain of
the reference, with consequently far fewer differences than the other strains), the average
number of SNPs per strain is 2.8M.
Nucleotide diversity in NIH-HS progenitors
Sequence diversity in the NIH-HS progenitors has the following characteristics. First,
diversity between all pairs of strains is similar, so that there are no extremely sequence
divergent strains (Supplementary Figure 1). Second, in total 29% of 7.2M SNPs are private
to a strain, hence unique haplotypes are relatively common in the NIH-HS. Third, regions of
low diversity are small (median 400kb), with no blocks over 35 Mb (Figure 1a). Within
divergent regions, there is a median of 151 differences per 100kb (Figure 1b).
In comparison with the eight inbred strains that founded the mouse HS4,10, the rat founders
are less diverse (10.2M SNPs in the mouse founders), but that diversity is more
homogeneous: in the mouse genomes, long tracts of identical haplotypes alternate with
segments of much greater diversity (Figures 1a, 1b).
Phenotypes and genotypes
The NIH-HS rats were phenotyped with a protocol that includes six disease models (anxiety,
diabetes, hypertension, aortic elastic lamina rupture, multiple sclerosis, osteoporosis) and
et al. Page 3
Nat Genet. Author manuscript; available in PMC 2014 January 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
measures of risk factors for common diseases (e.g. lipid and cholesterol levels and cardiac
hypertrophy)11(Table 2). In total, 160 phenotypes were measured (Supplementary Table 1).
We selected 1,407 animals for genotyping and 198 non-phenotyped parents, together with
the HS founders.
We designed a high density Affymetrix SNP genotyping array (RATDIV), using sequences
from 13 inbred strains, which interrogated 803,485 SNPs. The SOLiD and RATDIV calls
agreed at 99.98% of the 560,000 SNPs segregating in the 8 NIH-HS founders. We
genotyped the NIH-HS with the array, and reconstructed the mosaics of NIH-HS founder
haplotypes from 265,551 polymorphic high quality SNPs. In the NIH-HS the mean minor
allele frequency is 22% (Figure 1c) and linkage disequilibrium falls below 0.2 (median R2)
within 1Mb on the autosomes (Figure 1d). Four pairs of loci show high interchromosomal
LD, due to mis-assembly of the reference sequence used here (Rnor3.4); these loci were
excluded from the analysis (Supplementary Table 2).
Quantitative Trait Loci
The NIH-HS contains individuals of varying relatedness that generate population structure
and hence false positive genetic associations. We evaluated two strategies for dealing with
relatedness; mixed models in which the genotypic similarity matrix between individuals
modeled their phenotypic correlation12, and resampling methods to identify loci that
replicate consistently across multiple QTL models fitted on subsamples of the mapping
population13. In both strategies, QTLs were detected by haplotype association14.
We compared the methods by simulation to find out which best controlled the false positive
rate while retaining power. Mixed models performed better than resampling when
phenotypes were simulated to be normally distributed, but the reverse was true for non-
normally distributed phenotypes (i.e. binary phenotypes and those with a negative binomial
distribution). Since these methods have different advantages, we mapped all traits with both
methods, but only report those QTLs detected at false discovery rate (FDR) of 10% by that
method which performed best for each trait (thresholds in Supplementary Table 1). Figure 2
shows a genome scan for one phenotype (platelet aggregation), revealing three loci at 10%
FDR.
We identified 355 QTLs for 122 phenotypes with a mean of 2.9 QTLs per phenotype
(Supplementary Table 3). The number of QTLs per phenotype and the QTL effect sizes
(Figure 1e) have markedly skewed distributions, with a median effect size of 5% (mean
effect size 6.5 %). Large effect QTLs are rare: only 22 QTLs explain more than 15% of the
variance. We identified 28 QTLs that explained less than 2.5% of the phenotypic variance.
Figure 1f shows the correlation between the heritability and the total variance explained
jointly by the detected QTLs. On average the QTLs explain 42% of the heritable phenotypic
variance. In comparison with QTLs mapped in other rat crosses in the Rat Genome
Database, there is significant overlap with NIH-HS QTLs for the number of arterial elastic
lamina ruptures, total cholesterol levels and heart weight (at a nominal p-value of 0.05;
Supplementary Table 4).
We estimated the QTLs’ confidence intervals by simulating a large number of QTLs
throughout the genome with various effect sizes, and calculated the distribution of the
confidence intervals’ widths as a function of their significance (Supplementary Figure 2).
The median size of the 90% confidence interval is 4.5Mb, on average containing more than
40 genes.
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Incorporation of sequence with mapping data
We investigated the extent to which our near complete catalogue of segregating sequence
variants would identify genes and causative mutations. The HS permits a test, called merge
analysis6, of whether a variant is responsible for phenotypic variation, under the assumption
that a single imputed variant, or variants on a single progenitor haplotype, are causal.
Because genetic variation segregates in the form of the progenitor haplotypes in the HS,
QTLs can always be explained by variation in the haplotypes. When a QTL is due to a
single variant though, genotypic variation at the variant will explain phenotypic variation
better than progenitor haplotypes. To measure whether a single variant explains the QTL we
calculated the difference d = logPmerge – logPhap where logPhap, is the maximum negative
log 10 p-value of the haplotype test of no association and logPmerge is the maximum logP of
all merge logP values of variants under the QTL. Any imputed variant that exceeds the
maximum haplotype logP is termed a candidate variant. If d<0 then no candidate variants
exist at the QTL. We investigated the characteristics of these candidate variants at 343 QTLs
mapped using mixed models: at 131 QTLs (38%) we identified at least one candidate variant
(Supplementary Table 3).
There are three ways in which focusing on these candidate variants helps identify genes at a
QTL. First, we increase resolution by ruling out the great majority (usually over 90%) of
sequence variants under most QTLs as being causal. We found 28 QTLs at which only a
single gene contained candidate variants (Table 3). An example is Catenin-delta 2 (Ctnnd2)
at a QTL for an anxiety-related phenotype (Figure 3a). CTNND2 is a protein found in
complexes with cadherin cell adhesion molecules at neuronal synapses15. Figure 3b shows
another example for a locus influencing heart weight, where out of 82 coding genes under
the QTL, only Shank2 contained candidate SNPs. Shank2 encodes a synaptic protein 16 not
previously associated with cardiovascular physiology.
Second, merge analysis identifies some candidate variants lying within coding regions.
Those predicted to affect protein structure are more likely to be causal. Thus we identified a
potential causal nucleotide in a QTL for antibody recognition of CD45RC on CD4+ and
CD8+ T cells (Figure 3c). The antibody used binds to the CD45RC isoform, which expresses
a C-domain, encoded by the sixth exon, in which we found a candidate variant changing an
amino acid (p.Arg114His).
At 43 out of 91 non-synonymous candidate variants, where similar protein structures were
available17 we predicted the structural consequences of mutations (for a further 48 candidate
variants there were no homologies with known protein structures). Nine genes, listed in
Table 3, contained candidate variants for which structural evidence suggests protein
structure or interactions might be altered.
An example is shown in Figure 3d, for the protein TBX21, encoded by a gene under a QTL
influencing the proportion of CD4+ cells with high expression of CD25.) Here the candidate
variant changes glycine to arginine (p.Gly175Arg). The additional arginine could alter the
DNA-binding characteristics of this protein.
Figure 3e shows the crystal structure of human ABCB10, a mitochondrial transporter
induced by GATA1 during erythroid differentiation18,19. The candidate variant
(p.Thr233Met), predicted to influence mean red cell volume, maps to a position in the
protein structure where the residue side chain points to the centre of the transporter channel
(Figure 3e). Threonine has a polar uncharged side chain while methionine has a hydrophobic
side chain, a difference likely altering transporter function.
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Third, merge analysis eliminates candidate genes at a QTL that are distant from any
candidate variant. This approach confirmed a well-established relationship between a cluster
of apolipoprotein genes at a QTL on chromosome 1 and cholesterol biosynthesis (HDL,
LDL and total cholesterol). Similarly, merge analysis identified a locus influencing platelet
aggregation, on chromosome 4, that harbors the von Willebrand factor gene, encoding a key
glycoprotein involved in blood coagulation.
Merge analysis also contributes to an understanding of the pathogenesis of experimental
autoimmune encephalomyelitis (EAE), an autoimmune neuroinflammatory disease with
clinical and pathological similarities to multiple sclerosis (MS)20. The MHC class II region
on chromosome 20 (Eae1) is known to influence EAE susceptibility. However, attempts to
identify the responsible gene have had limited success. In this study, the two variants most
likely to be causative for the QTL on chromosome 20 (i.e. highest logP) are a variant in an
intron of Btnl2 and a variant 274 bp upstream of RT1-Db1, both in the class II region. The
human orthologue of RT1-Db1, HLA-DRB1, is associated with multiple sclerosis with risk
allele HLA-DRB1*15:0121.
Single variants rarely account for NIH-HS QTL genetic effects
Unexpectedly 212 QTLs (62%) had no candidate variant (Figure 4a). We considered four
explanations for this observation: (i) causative variants were missing from the sequence
catalogue; (ii) haplotype mapping is biased towards QTLs without candidate variants; (iii)
the merge analysis underestimated statistical significance compared to single marker
association; (iv) the presence of multiple causal variants.
First, causal variants may have been missed because our sequence data are incomplete.
Despite linkage disequilibrium extending over a few megabases, not all variants are tagged
by a nearby variant with identical strain distribution pattern (SDP) in the founders. For
example, only 50% of the structural variants are tagged by a SNP lying within 1Mb.
However, because only a limited set of possible SDPs exist in the HS, we can test whether
missing genotypes are responsible for failure to detect candidate variants. We generated
SDPs for all diallelic and tri-allelic variants at every locus within the 212 QTLs and tested
each by merge analysis, to see how many would have been candidates. Only 44 QTLs had
candidate diallelic variants and 165 had diallelic or triallelic variants. Thus if the effects are
attributable to a single diallelic variant that we had failed to sequence, then there are still 168
QTLs (49%) without a candidate variant. If the effects are attributable to a di-allelic or tri-
allelic variant, the fraction reduces to 14%. However, triallelic SNPs are very uncommon
and therefore unlikely to explain the large number of QTLs without candidate variants.
Second, haplotype mapping might simply not be powerful enough to detect candidate
variants, or be biased towards QTLs without candidate variants. We addressed the first
possibility by simulation and show the results in Figure 4a. In each case we report the
distribution of the difference d between maximum merge and haplotype logPs, so that if
candidate variants exist then d > 0 (where d = logPmerge – logPhap as defined above). When
simulated QTLs arise from single causal variants, merge analysis does indeed identify
candidate variants at almost all QTLs placed at random regions of the genome as well as at
QTLs simulated in the same locations as the detected QTLs.
We also considered the performance of the method at QTLs where a single variant is highly
likely to be the causal variant, namely at cis-acting expression QTLs 22,23. We tested 1,398
eQTLs detected in the hippocampus of HS mice24. We found that the merge analysis
identified variants that exceed the haplotype-based test at 97% of QTLs (Figure 4b).
Interestingly, when we carried out the same analysis on trans eQTLs, the distribution of d
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values was similar to that seen for the rat phenotypic QTLs (Figure 4b). This difference
between cis and trans-eQTLs is true across all logP values, indicating that the difference is
not due to lower power to detect trans eQTLs.
Since mapping QTLs using haplotype analysis might bias results towards finding loci
without candidates (a winner’s curse is likely to operate), we used merge analysis to map
QTLs genome-wide. The two methods do not identify the same QTLs (152 are unique to the
merge method) but the merge method identified 16% fewer than the haplotype method.
Importantly, only 9% of the merge-identified QTLs had no candidate variants (Supplemental
figure 3). Consequently haplotype mapping will overestimate the number of QTLs without a
candidate variant while merge analysis underestimates it. Therefore our best estimate of the
proportion of QTLs without candidate variants is obtained from combining both methods.
From the set of QTLs found by either merge or haplotype mapping we find that 44% of
QTLs cannot be explained by single causal variants (instead of 62% when only the
haplotype-based QTLs were considered). Thus while a winner’s curse does operate in favour
of the haplotype analysis, it cannot account for all QTLs without a candidate variant.
The third explanation was that the merge analysis under-estimates statistical significance.
We compared the performance of the merge analysis with single marker association at
genotyped SNPs. Across all phenotypes, the R2 between the logP values was 0.9; agreement
was strongest for the most highly associated SNPs. This result indicates that merge analysis
performs as well as SNP analysis.
Finally, we investigated the extent to which multiple variants at QTLs would account for our
findings. We investigated the consequences of a variety of complex QTL architectures by
simulation and show the results in Figure 4a. Simulating multiple causal variants, on
different haplotypes, reduced the frequency that any single variant exceeded the maximum
haplotype logP, although this was still insufficient to mimic the observed distribution
(Figure 4a). Simulating irreducible haplotypic effects arising from the reconstructed
haplotype mosaics in the HS (rather than from a selection of sequence variants) also led to
fewer QTLs with candidate variants (Figure 4a), although again it did not match the
proportion observed with the real QTLs. Our simulations suggest that the presence of
multiple causal variants at a locus accounts in part for the failure to find candidate causal
variants.
Concordance between species
It is often assumed that genetic loci underlying a phenotype identified in one species are
homologous to those underlying the same phenotype in another, and that natural variation
within these loci will pinpoint the same genes 25-27. However, there have been no genome-
wide tests of the hypothesis for natural variation. Our data allowed us to examine whether
genes and QTLs identified in the NIH-HS overlapped those found for the same phenotypes
in a mouse HS10.
In total 38 measures were common to both studies, and were mapped using the same mixed
model method. Only one measure, the ratio of CD4+ to CD8+ T-cells, showed overlap
(using a FDR of 10% and looking in the 90% QTL confidence interval) but this was not
significant (empirical p-value of 0.1). We repeated the analysis using QTLs called at a lower
significance threshold (20th percentile of the extreme value distribution for each measure)
and expanding the width of each QTL to 8Mb. Table 4 shows overlap for eight phenotypes,
only two of which were significant at an empirical p-value of 0.05: serum urea concentration
and the ratio of CD4+ to CD8+ T-cells. Overall, genetic variants in orthologous genes rarely
contribute to the same phenotype in the two populations.
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To test whether QTL overlap existed within similar pathways we compared the enrichment
of KEGG pathways28. Only one measure, the proportion of B cells in the white blood cells,
showed significant enrichment of a pathway (corrected p-value < 0.05). Even at a more
relaxed significance threshold of 0.05 (non-corrected for multiple testing), only three
measures show significant enrichment in the same KEGG pathways.
Discussion
Using 1,407 outbred rats we have mapped 122 phenotypes and identified 355 QTLs at high
resolution. We have shown how combining sequence with high resolution mapping data can
lead to the immediate identification of candidate genes, and in some cases to the
identification of candidate causal variants at many QTL. We highlight two examples here.
The locus on chromosome 10 regulating frequency of CD25+ CD4 T cells, and the
frequencies of CD4 and CD8 T cells, has previously been shown to control CD4 and CD8
frequencies in a cross between ACI and F34429, both represented in the NIH-HS rats. The
amino acid substitution at position 175 (p.Gly175Arg) of the TBX21 protein is a very strong
causal candidate at this QTL since this domain is important for DNA interactions. Tbx21 has
been implicated in the genetic control of regulatory T cells30, a subset of T cells with high
surface expression of CD25, and might indirectly regulate the frequency of CD4+ and CD8+
T cells via the transcriptional repressor Sin3a31,32.
We implicated Abcb10 in red blood cell differentiation. Evidence from mouse knockouts
indicates that this gene is essential for erythropoiesis18,19,33. The p.Thr233Met mutation
positions a larger, bulkier residue into a region that is tightly packed in the open-outwards
conformation of ABC transporters, potentially interfering with conformational changes
which are essential for transport of the substrate.
Two noteworthy features of the genetic architecture of complex traits in the rat emerge from
this study: (i) the contrast with human GWAS findings; (ii) about half of QTLs cannot be
attributed to a single causal variant. We discuss these points below.
Rat and mouse HS experiments differ from human GWAS in two ways. In the rodent
GWAS, far fewer subjects are required to detect a significant effect and fewer loci of larger
effect explain more of the variance. In rats the median proportion of heritability explained
by joint QTLs is 39.1% (mean 42.3%), in mice 32.2% (mean 42.0%). In humans the
equivalent figure is often less than 10%.
One explanation for these differences is the markedly different allele frequencies: human
populations are characterized by a preponderance of rare alleles (minor allele frequency less
than 1%); HS populations have a relatively uniform distribution of minor allele frequencies
(Figure 1c). However, it is important to realize that the mouse and rat differ in the degree of
segregating variation (in the rat NIH-HS there are 7.2M SNP sites, compared to 10.2M in
the mouse HS). In the rat there are 2.8M SNPs per HS strain, the corresponding number in
the mouse HS is 4.4M. In other words, total sequence variation per se is not a critical
determinant of the explanatory power of the QTLs. Furthermore, the heritabilities of the
homologous phenotypes in rat NIH-HS and in HS mice are highly correlated (0.6, p-value
0.0002) (Supplemental Figure 4), implying that the additional sequence variation in the
mouse does not give rise to an increase in heritability.
The failure to detect a single candidate variant at half of rat QTLs was surprising. We
showed that while reliance on haplotype mapping can underestimate the number of QTLs
without candidate variants, after taking this bias into account (by detecting QTLs with
merge and haplotype analysis) there is still a large fraction (44%) of QTLs without
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candidate variants. The contrast between the 44% figure and the 97% that emerged from an
analysis of variants at cis-eQTLs is striking. It is also notable that the findings from trans-
eQTLs are so similar to those of the rat phenotypes (Figure 4) suggesting that cis-eQTLs are
atypical. Our simulations indicate, but have not proven, that multiple causal variants are in
part to blame. At present, we can only conclude that single causal variants are not always
responsible for the genetic signal. Whether the lack of single causal variants at many loci is
a general feature of loci influencing complex traits or not remains to be determined.
One simple interpretation of human GWAS is that each locus represents the presence of a
single, relatively common, functional variant. Our results indicate that more complex
models are required. Such alternative hypotheses exist, in which for example multiple alleles
of varying frequency at the same or closely linked loci, contribute to the signal. Identifying
the correct model of genetic action is critical for finding causative variants, since incorrect
assumptions about the number and mode of action of genetic variants reduce power and can
lead to false positive results34. The extent and nature of sequence diversity may be partly
responsible for the complex way sequence variation acts at a QTL.
It is sometimes hoped that loci found in the rat could be typed and identified in humans, thus
providing a cost-efficient way to find medically relevant genes. We observe some examples
where the same loci act in different species, the most notable example being for variation in
the ratio of CD4+ to CD8+ T-cells: the locus lies within the MHC in rats, humans35 and
mice36 and its molecular nature in mouse has been identified as a deletion in the promoter of
the Class II H2-Ea gene36. However formal tests for overlap between rat and mouse at the
level of the gene or of a pathway yielded little that was statistically significant. Since the
amount of sequence variation segregating within the two HS populations is relatively
limited, failure to detect shared loci may be due to sampling. Also, the relatively small
number of genes found for each phenotype reduces our power to detect pathways. We
suspect that currently it is not possible to accurately assess overlap between the two species.
This study strengthens the rat’s role as a model organism in physiology and disease. Our
mapping and sequencing data provide an important resource for addressing many
biomedical questions.
Methods
Sequencing of HS founder genomes
Genome sequencing—DNA libraries for SOLiD sequencing were generated from
genomic DNA from samples of the original rats that were used to create the HS population.
The libraries were generated using standard protocols (Life Technologies) and had a median
insert size of between 109 and 196 bp. All libraries were sequenced with fragment (50 bp)
and paired-end (50+35 bp) runs using SOLiD 4 and SOLiD 5500 sequencers to a depth of at
least 22x base coverage for each of the eight HS progenitors and for the strain LE/Stm,
which was used to estimate error rates in comparison with hand-finished BAC sequence.
Sequence alignment—Sequence reads were mapped against contigs of the Rnor3.4 rat
reference genome assembly (reference strain BN) using BWA v0.5.937 with parameters -c –l
25 –k 2 –n 10. Alignments from different libraries of the same HS progenitor were
combined into a single BAM file.
Variant calling—Variant calling was performed independently on each strain. SNPs and
short indels (<10bp) were called using a modified Samtools38 pipeline: Only unambiguously
mapped reads were used. Sites with coverage below 4 or over 2000 were not used for SNP
calling. Read bases with base-quality below 30 were ignored. Duplicate reads starting at the
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same position and mapped to the same strand as another read were discarded as likely PCR
artifacts. Each of the called alleles had to be supported by at least one read where the variant
mapped within the seed part of the read (first 25 bases). Non-reference alleles called with
fewer than 3 reads were set to missing. Variable sites with more than 2 alleles within one
founder were set to missing. The remaining variants were considered to be homozygous
non-reference alleles (frequency of non-reference call > 2/3) or heterozygous alleles
(frequency between 1/3 and 2/3) – however, we set to missing the small number of
heterozygote calls as these were likely to be artefacts, for example due to unknown
duplications. We later attempted to call all the missing genotypes by imputation (see below).
Copy number variants were called using depth-of-coverage approach implemented in
DWAC-Seq v. 0.56 (https://github.com/Vityay/DWAC-Seq) using default parameters.
Structural variants (SVs) were called using discordant pair mapping implemented in 1-2-3-
SV v. 1.0 (https://github.com/Vityay/1-2-3-SV), requiring unambiguous mapping of both
paired tags and at least 4 tag pairs per SV event. SV calls from these tools were merged.
Prediction of the functional effect of each variant was performed by Variant Effect Predictor
tool VEP 2.1 tool39.
We defined inaccessible regions of the HS rat genomes in a similar way as was done for
mouse genomes4. A base was considered as accessible if it did not overlap simple, tandem
repeats or low complexity sequence (defined by Dust, source: Ensembl release 66; http://
www.ensembl.org), was not covered by more than 150 reads, and average mapping quality
was at least 40. Nucleotide positions within 15bp of indels were also considered as
inaccessible for SNP calling.
False positive and false negative rates—Thirteen BACs from the strain LE/Stm were
sequenced using capillary methods, assembled and manually edited, producing a total of 2.1
Mb finished sequence. BAC sequences were aligned using BLAT40 For each BAC a single
contiguous alignment was obtained, which was used to extract single base changes (SNPs)
short indels (1-10 bp) and structural variants (100 bp and above). False positive and false
negative rates were estimated from 1.9 Mb of genome sequence syntenic between BACs and
genome assembly, excluding low quality BAC sequence (as defined by the BAC finishing
team) and inaccessible regions (as defined above). False positive and false negative rates
within this 1.9Mb were estimated from the discordance between our allele calls and those in
the BACs.
Low false positive rates were independently confirmed by analysis of a randomly selected
subset of 96 SNPs and 96 indels using PCR-based resequencing. Oligonucleotide primers
were selected to amplify 300 bp fragments around the candidate polymorphism. When
amplification was successful (SNPs: 84, indels: 80), amplicons were sequenced on an
Applied Biosystems ABI 3730XL sequencer using Big-Dye terminator and analyzed with
Polyphred software manually.
For CNVs and SVs 184 variants were selected and PCR primers were designed in such way
that the presence or absence (depending on the variation type) of a PCR product could
confirm the presence of the variation. After PCR, samples were run on agarose gel and
analyzed manually. Of the 184 amplicons, 93 gave a PCR product. Of these 93, a group of
39 variants that were predicted SVs in the NIH-HS founders, were also confirmed by PCR
in BN/NHsdMcwi indicating that these are probably assembly errors in the current reference
genome (Rn3.4). Of the remaining 54 variants, 53 gave a banding pattern according to our
expectance and in one case the predicted variation type was not correctly predicted.
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Sequence divergence—Genotypes and genome accessibility data for HS rats (this study)
and HS mice4 were used to characterize patterns of nucleotide diversity in these two panels.
We partitioned each genome into non-overlapping windows such that each window
contained 100 kb of accessible sequence (defined relative to the rat BN strain or mouse
C57BL6 strain). The number of sequence differences per window was calculated for all
windows and for all possible pairs of strains.
Low diversity regions—We found the spatial distribution of pairwise differences in the
rat progenitors was bimodal with modes at 0 and 150 SNPs per 100 kb window (Figure 1b).
Based on this distribution we defined a region of low nucleotide diversity between two
strains as consecutive windows with nucleotide diversity below 13 SNPs per 100kb window.
Phenotyping
Animals—The rat NIH-HS originates from a colony established in the 1980s in NIH3.
Since its creation, the stock has been bred using a rotational outbreeding regime in order to
minimize the extent of inbreeding, drift, and fixation.
Phenotyping—A full description of the phenotyping protocol is given in Supplementary
Note (“Phenotyping”).
All procedures were carried out in accordance with the Spanish legislation on “Protection of
Animals Used for Experimental and Other Scientific Purposes” and the European
Communities Council Directive (86/609/EEC) on this subject. The experimental protocol
was approved by the Autonomous University of Barcelona Ethics committee (permit
CEEAH 697).
Quality control, covariate analysis and normalisation of phenotypes—The
phenotype data were uploaded to a database (Integrated Genotyping System41) in batches
over the three years of data collection. All relevant covariates were evaluated for their effect
on each measure. The final set of covariates and transformations applied to each phenotype,
as well as the number of data points for each measure, are given in Supplementary Table 1.
Genotyping
The RATDIV array was developed as a general SNP genotyping array, applicable both to
the rat HS project and other populations of laboratory rats. Full descriptions of the
development of the rat array and of the selection of the 265,551 SNPs used in this study are
given in the Supplementary Note (sections “Development of the rat array” and “Selection of
SNPs for this study” respectively).
Linkage disequilibrium analysis
Linkage disequilibrium (LD) between SNPs in the rat and mouse HS was calculated using
PLINK42 from the genotypes called for the 261K autosomal rat SNPs and 12K autosomal
mouse SNPs10. In the rat HS, eight regions with very high interchromosomal LD were
identified, and excluded from subsequent analyses (Supplemental Table 2). Using UCSC
liftover tool43, these regions mapped in the new rat reference genome assembly (RGSC 5.0)
to the regions with which they were in high LD in the current assembly (Rnor3.4).
QTL Mapping
Reconstruction of HS rat genomes as mosaics of founder haplotypes—All
genetic analysis was performed using R44. We used the R HAPPY package14 to calculate
the descent probabilities from the eight HS founders for each animal at each of 265,551
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inter-markers intervals, and then averaged these probabilities over 90kb windows, so that we
eventually worked with 24,196 probability matrices. The density of the 265k SNPs was
much greater than the density of recombinants in the HS, so the averaging did not cause any
reduction in mapping resolution (most QTLs are mapped to intervals over a Mb wide,
containing over ten 90kb intervals).
Accounting for confounding in the HS—HS rats with different levels of relatedness
were used in this study, including siblings, half sibs, cousins, uncles, great-uncles, etc. This
unequal genome-wide genetic similarity means that correlations exist in the HS between
distant markers. These long-range correlations (as opposed to short-range correlations due to
physical linkage) can be responsible for false associations if not accounted for. We used two
methods to control for unequal relatedness: Resample Model Averaging (as implemented in
BAGPHENOTYPE 13) for non normally distributed phenotypes, and Mixed Models for
normally distributed phenotypes. Information on the scope and the performance of the
methods is given in the Supplementary Note (section “Comparison between mixed models
and resample model averaging”). Because most of the phenotypes were normally distributed
and the merge analysis was run in the mixed model framework, we present the mixed
models briefly here. They were implemented in R so that haplotype mapping could be
carried out using the descent probabilities output by HAPPY14. The model used to test for
association between the ancestral haplotypes segregating at a locus L and phenotypic
variation was:
(1)
where yi is the phenotypic value of the rat i, βc the regression coefficient of covariate c and
xic the value of the covariate c in rat i. Importantly, the covariates include a dummy intercept
term. TLs is the deviation in phenotypic value that results from carrying one copy of a
haplotype from strain s at locus L and PLi(s) the expected number of haplotypes of type s
carried by rat i at locus L output by HAPPY14. ui and εi are random effects, with cov(ui,uj) =
σg2Ki,j and cov(εi,εj) = σe2Ii,j where σg2 and σe2 are estimated in the null model (no locus
effect, TLs=0) using the R package EMMA12. K is the genetic covariance matrix, and is
estimated from the genome-wide genotypic data using identity by state (IBS, the proportion
of shared alleles between any two animals). The IBS matrix was calculated using the R
package EMMA12. I is the identity matrix. The total covariance matrix V= σg2K + σe2I can
be factorized as V=A2. Writing the equation (1) in matrix form,
(2)
Pre-multiplying (2) by A−1 gives a transformed equation
in which the variance-covariance structure of the random term A−1(u + ε) is now
proportional to a diagonal matrix and so can be fitted as a standard linear model.
Thresholds and confidence intervals—Calculations of the significance thresholds
(when the phenotype was analysed with mixed models), inclusion probability thresholds
(when it was analysed by resample model averaging), and confidence intervals are described
in the Supplementary Note (section “QTL calling”).
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Incorporation of sequence into QTL mapping
Implementation of the merge analysis in the mixed model framework—Merge
analysis is a form of imputation appropriate to HS-type populations whose genomes are
mosaics of known haplotypes. Merge analysis asks two questions at each imputed variant: is
the variant associated with the phenotype? (a standard test of association), and is it as
significant as the test of haplotype association in the locality of the variant? We
implemented merge analysis6 in a mixed models framework by comparing the models:
(2 above)
(3)
where V is a sequence variant in interval L, and MV is the merge matrix for the variant,
formed by summing those columns of PL that carry the same allele at V (each column of PL
represents one founder strain). This can be computed efficiently by defining a matrix BV
that encodes the columns to be merged such that MV = PVBV. This test is applied at every
variable site in the catalogue of single nucleotide variants that segregate between the 8 HS
founders. From a statistical point of view, there is no difference between two variants with
the same strain distribution pattern at a locus; they will give the same merge analysis result.
Because the two models (2), (3) are nested, the best possible fit (in terms of variance
explained) is obtained with the haplotype model (2). If the QTL arises from variation at a
single variant V, the fit of the merge model (3) for variant V will be as good as the fit of (2)
and its significance will be greater due to the fewer number of degrees of freedom (for a
diallelic variant, the degrees of freedom is 1 rather than 7 for the haplotype model). The
merge model is fitted by multiplying by A−1 as before.
Simulating all possible strain distribution patterns at a QTL—For each QTL
lacking variants with a merge logP exceeding the haplotype logP, we looked for unobserved
causal variants that might not have been sequenced. We simulated candidate variants with
every possible strain distribution pattern (SDPs; 127 possible SDPs for diallelic variants,
1,094 possible SDPs when allowing for 3 alleles). The simulated variants were repeated
within each QTL interval.
Simulating different QTL architectures—To investigate the hypothesis that failure to
detect candidate variants by merge analysis reflected a complex architecture of the QTLs,
we simulated QTLs arising from a single causal variant, QTLs arising from multiple causal
variants within the same locus and/or multiple causal variants at linked loci, and QTLs
arising from haplotypic effects not reducible to individual variants. In all cases the
phenotypes were simulated from three components: a genetic random effect explaining 20%
of phenotypic variation, uncorrelated errors explaining 75% of phenotypic variation, and a
single QTL explaining 5% of phenotypic variation. When multiple causal variants were
simulated, each explained the same proportion of phenotypic variation (5% divided by the
number of causal variants). The effect sizes calculated a posteriori could be quite different
from their target values due to correlations between the different components of the
simulated phenotypes. For the simulations reported in Figure 4a, either a single causal
variant was simulated, or nine causal variants in three linked loci (each locus within 2Mb of
the central locus and distant by at least 200kb from each other locus). Alternatively, the
probabilities PL were used to simulate irreducible QTLs. We analysed each simulation by
merge analysis and when logPhaplotype was between 4 and 6 (to have a similar distribution of
logP values to that of the rat QTLs) we calculated d = max logPmerge – max logPhaplotype.
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We compared the distribution of d from the different simulation sets to determine the likely
genetic architecture of the QTLs.
eQTL mapping and merge analysis in the mouse Heterogeneous Stock—
Hippocampus expression levels in 460 HS mice measured using 12 thousand probes of
Illumina Mouse WG-6 v1 BeadArrays 24 were mapped to the mouse ancestral haplotypes in
the mixed model framework. QTLs were called in the same way as for the rat QTLs but
using a confidence interval of 8Mb and a significance threshold of 4. cis-eQTLs were
defined as within 2Mb of the beginning of the probe, and trans-eQTLs as those QTLs on a
different chromosome from that of the probe or more than 10Mb away from it. Merge
analysis was carried out at each eQTL and the difference between the maximum merge logP
and the maximum haplotype logP was calculated.
Homology modeling—To assess the potential effect of mutations on protein structure,
homology models of target proteins were constructed and analysed. Amino acid sequences
of target proteins were retrieved from Ensembl or UniProt databases45 and analysed using
HHPred46 web server to identify structures with similar amino acid sequences in the Protein
Data Bank17 for homology modelling with MODELLER47. Potential location of the
mutation-bearing side chains (buried or surface exposed) and effect on the structure-function
(e.g. disturbed hydrophobic core) was evaluated manually in PyMOL (The PyMOL
Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC.).
Genetic architecture
Heritability—Heritability is defined as the ratio of the genetic variance component by the
sum of the variance components estimated in the null mixed model (covariates but no QTL).
QTL Effect sizes and joint effect sizes—Effect sizes are defined as the ratio between
the fitted sum of squares and the total sum of squares in a model with covariates and without
genetic random component. Joint effect sizes are defined as the ratio between the fitted sum
of squares and the total sum of squares in a model without genetic random component
including covariates and all the QTLs called for a given phenotype. Including the genetic
random component would underestimate most of the effect sizes because part of the
variance would have been attributed to it. Thus the QTL effect sizes reported are probably
overestimates.
Number of genes under a QTL—The number of genes under each QTL confidence
interval was calculated using Ensembl protein coding genes and genes coding for micro
RNAs (downloaded from BioMart48).
Overlap with RGD QTLs and with QTLs detected in the mouse HS—The
calculation of the overlap between RGD and rat HS QTLs, and between mouse and rat HS
QTLs is given in the Supplementary Note (section “Overlap between sets of QTLs”).
Pathway analysis for the QTLs detected in the rat and mouse heterogeneous
stocks—Kyoto Encyclopedia of Genes and Genomes pathways were retrieved using R
KEGG.db package. We used INRICH 49 to find enrichment of pathways in the mouse and
rat phenotypic QTLs (as defined by the 90% confidence interval) called at a low
significance threshold (20th percentile of the extreme value distribution). We report the
empirical and corrected p-values reported by INRICH.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Sequence diversity among progenitor strains and genetic architecture of the rat NIH-
HS
a) Regions of low diversity in the rat (black) and mouse (blue) progenitors. The horizontal
axis shows the length in megabases of genomic regions with little sequence divergence (less
than 13 SNPs/100kb). The vertical axis shows the numbers of segments observed in the
eight progenitors. b) Sequence divergence in the progenitors. The horizontal axis is a
measure of pairwise sequence diversity, the number of sequence differences observed in
windows of 100 kilobases, the vertical axis gives the number of observations. The horizontal
axis is truncated at 800 sequence differences and the vertical axis at 3500 windows. c)
Minor allele frequencies in rat (gray & black), mouse (blue) and human (red) populations.
The rat analysis was performed with the set of autosomal markers used to reconstruct
haplotypes (261,684) as well as the complete set of 796,187 autosomal variants on the
RATDIV array. d) The extent of linkage disequilibrium (measured as R2) in the rat NIH-HS.
Distances between pairs of autosomal markers were binned (horizontal axis). The vertical
axis shows the median of the corresponding distribution of LD. e) The distribution of effect
sizes for the 343 loci mapped by mixed models in the rat NIH-HS. The horizontal axis is the
proportion of phenotypic variance attributable to each locus. f) The proportion of heritability
that can be explained by the joint effect of the QTLs detected for each phenotype. Each dot
represents a single phenotype, with the horizontal axis showing the heritability and the
vertical axis the joint QTL effect for that phenotype.
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Figure 2. Genome scan for platelet aggregation
The scan shows the results of a haplotype mixed model. The vertical scale is the negative
logarithm of the P-value (logP) for association with variation in platelet aggregation. The
peak on chromosome 4 harbors the von Willebrand factor gene that is identified through
sequence analysis as the causative gene.
et al. Page 19
Nat Genet. Author manuscript; available in PMC 2014 January 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 3. Merge analysis to identify causative genes and sequence variants
The top three panels (a – c) show, on the left, the scans for a whole chromosome, with the
name of the phenotype. The black lines represent the haplotype analysis and the blue dots
are the merge analysis results of testing for association with all sequence variants identified
in the progenitor strains. On the right is an enlargement of the highest peak showing the
location of candidate variants and genes. Candidate variants are those whose significance
exceeds that of the haplotype analysis (i.e. blue dots are above the highest value of the black
line). Genes are shown by red arrows. Panel (d) shows candidate variants on chromosome
10 for the proportion of CD4+ cells with high expression of CD25. The highest variant lies
within the TBX21 protein. The crystal structure of human TBX5-DNA complex (PDB code
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2X6V) maps the location of the rat TBX21 mutation Gly175Arg to the DNA binding
domain. The structure of TBX5 (green) complexed with DNA (blue) is shown in ribbon
representation. Gly93 is shown as spheres (C atoms in green, O atoms in red N atoms in
blue). Gly93 and corresponding Gly175 (rat) are conserved. Side chains of two arginines
that mediate interactions with DNA are shown as sticks. Panel (e) shows a candidate variant
in the Abcb10 gene on chromosome 19 for a locus influencing mean red cell volume. The
structure of the homodimeric ABCB10 (PDB code 4AYT) is shown in ribbon
representation, with the monomers in blue and green. Two ATP analogues (ACP) and side
chains of Thr268 are shown as spheres (C atoms in green, O atoms in red N atoms in blue
and P in orange). Thr268 in the human protein corresponds to the conserved Thr233 residue
in the rat protein. The rat ABCB10 mutation Thr233Met lies in the central cavity of the
translocation pathway. Amino acid sequence identity between rat and human ABCB10 is
84% (587 aligned residues).
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Figure 4. Merge analysis and simulations
The figure plots the difference between the negative logarithm p-value of association (logP)
of imputed variants and haplotype-based logP for the rat QTLs (4a) and a set of 1,386 cis-
acting and 7,464 trans-acting expression QTLs mapped in a mouse HS (4b). In cases where
there is a single causal variant at a QTL, the logP of some imputed variants will exceed that
of the haplotypes, so that the mean of the distribution of the difference between these two
logP values will be greater than zero. This is shown as a blue histogram on the plot 4a. The
distribution observed for the phenotypic QTLs, shown in red in 4a, has a mean less than
zero. The results of simulating haplotypic effects are shown in yellow, and in orange the
consequence of simulating multiple causative variants. The distribution of the difference in
logP for the cis-eQTLs is shown in blue in 4b to highlight the resemblance with the results
of simulating single causative variants. The distribution for the trans-eQTLs is shown in
green in 4b and is most similar to that for the phenotypic QTLs.
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Table 1
Sequence variation in the eight progenitor strains of the NIH-HS rats.
The amount of sequence mapped to the reference is shown in gigabases (Gb), the coverage, the percent of the
genome deemed inaccessible, and the numbers of the three classes of variants compared to the reference
strain. Note that ‘private variants’ refers to the number of variants that distinguish a specified strain from all
the others; most of the alleles private to BN/SsN will be reference alleles.
Strain
Gb of
mapped
data
Coverage
% of
genome
inaccessible
SNPs PrivateSNPs Indels
Private
indels
Structural
variants
Private
structural
variants
ACI/N 65.9 26.3 12.6 2,883,405 228,468 166,425 12,646 19,499 756
BN/SsN 54.4 21.7 9.4 71,038 563,308 0 14,839 27 4,203
BUF/N 62.3 24.9 12.7 2,748,633 125,202 172,934 7,195 22,176 1,002
F344/N 77.9 31.1 11.8 2,831,144 97,951 157,522 5,007 25,257 1,003
M520/N 72.5 28.9 12.3 2,836,898 89,277 170,031 5,008 24,090 915
MR/N 62.4 24.9 12.3 2,664,124 223,514 151,099 12,005 18,306 1,004
WKY/N 63.4 25.3 12.1 3,088,953 496,327 164,634 23,979 28,270 3,357
WN/N 62.3 24.9 12.2 2,698,493 249,563 154,769 13,541 18,563 700
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Table 2
Summary of phenotypes collected.
Phenotype Disease model Number of
measures
Age (weeks)
Coat colour 4 7
Wound healing 1 7 and 17
Fear related behaviours Anxiety 10 8 to 10
Glucose tolerance Type II diabetes 6 11
Cardiovascular function Hypertension 2 12
Body weight Obesity 1 13
Basal hematology 26 13
Basal immunology 34 13
Induced neuroinflammation Multiple sclerosis 11 13 to 17
Bone mass and strength Osteoporosis 43 17
Arterial elastic lamina ruptures 6 17
Serum biochemistry 15 17
Renal agenesis 1 17
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Table 4
Syntenic QTLs mapped in the rat and mouse HS for the same measure.
The table shows the 8 measures (out of 38) that have syntenic QTLs, the QTL coordinates (chromosome, start
and stop) and the p-value of the overlap (one p-value per measure).
Phenotype Rat chr. Rat QTL (Mb) Mouse
chr. Mouse QTL (Mb)
P-value of
overlap
CD4/CD8 ratio 2 80.51 - 88.51 8 71.7 - 79.7
CD4/CD8 ratio 20 1.00 - 21.13 17 29.77 - 37.77
CD4/CD8 ratio 9 0.16 - 8.16 17 50.77 - 58.77 0.009
Serum urea 3 42.22 - 50.22 2 62.25 - 70.25 0.017
Serum calcium 12 32.82 - 40.82 5 122.62 - 130.62 0.082
White blood cells 10 57.69 - 71.77 11 64.92 - 72.92
White blood cells 20 47.41 - 55.24 10 40.74 - 48.74 0.115
T/B cells ratio 13 76.73 - 84.73 1 169.63 - 177.63
T/B cells ratio 20 37.59 - 45.59 10 36.25 - 48.68 0.149
Serum chloride 9 30.61 - 38.61 13 2.91 - 15.19 0.22
Monocytes 20 0.17 - 8.17 17 21.00 - 29.00 0.301
Serum total cholesterol 4 17.09 - 25.09 5 12.52 - 20.52 0.598
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